Filing Details

Accession Number:
0001209191-22-060487
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-09 16:17:55
Reporting Period:
2022-11-28
Accepted Time:
2022-12-09 16:17:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1652724 Lucira Health Inc. LHDX In Vitro & In Vivo Diagnostic Substances (2835) 272491037
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1877741 Ghazi Kashmolah 1412 62Nd Street
Emeryville CA 94608
Ex Vp & Chief Quality Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-28 7,537 $0.42 139,103 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct